Neurosense Therapeutics Ltd. ORDINARY SHARES is a security (CUSIP M74240108) tracked across SEC portfolio filings. 13 institutional managers reported $253K on Form 13F as of 2026-06-30.
| Manager | Location | Value | Shares |
|---|---|---|---|
| Yorkville Advisors Global, LP | MOUNTAINSIDE, NJ | $56K | 78,000 |
| Independent Advisor Alliance | CHARLOTTE, NC | $38K | 50,000 |
| UBS Group AG | Zurich, V8 | $37K | 49,096 |
| TWO SIGMA INVESTMENTS, LP | New York, NY | $34K | 44,445 |
| JANE STREET GROUP, LLC | NEW YORK, NY | $22K | 28,670 |
| COMMONWEALTH EQUITY SERVICES, LLC | WALTHAM, MA | $16K | 22,775 |
| PNC Financial Services Group, Inc. | Pittsburgh, PA | $16K | 21,150 |
| Pathstone Holdings, LLC | ENGLEWOOD, NJ | $12K | 16,528 |
| GEODE CAPITAL MANAGEMENT, LLC | BOSTON, MA | $12K | 15,870 |
| Creative Planning | Overland Park, KS | $9K | 11,911 |
| JONES FINANCIAL COMPANIES LLLP | DES PERES, MO | $731 | 1,000 |
| SBI Securities Co., Ltd. | TOKYO, M0 | $184 | 255 |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | BIRMINGHAM, AL | — | 0 |